Effect of Peripheral Laser Iridotomy Placement on Post-operative Visual Function
NCT ID: NCT03352492
Last Updated: 2020-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2018-01-01
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting the Effect of Laser Peripheral Iridotomy
NCT04495491
The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma
NCT04912362
Effects of Selective Laser Trabeculoplasty
NCT00986141
Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs
NCT01417858
Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT)
NCT04036214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilateral iridotomy: Superior
Each subject in this single-arm study undergoes bilateral laser peripheral iridotomy surgery. Each participant will undergo superior laser peripheral iridotomy in one eye and temporal laser peripheral iridotomy in the fellow eye.
Superior laser peripheral iridotomy
Iridotomy placement between 11:00 and 1:00 o'clock
Bilateral iridotomy: Temporal
Each subject in this single-arm study undergoes bilateral laser peripheral iridotomy surgery. Each participant will undergo superior laser peripheral iridotomy in one eye and temporal laser peripheral iridotomy in the fellow eye.
Temporal laser peripheral iridotomy
Iridotomy placement at 3:00 or 9:00 o'clock
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Superior laser peripheral iridotomy
Iridotomy placement between 11:00 and 1:00 o'clock
Temporal laser peripheral iridotomy
Iridotomy placement at 3:00 or 9:00 o'clock
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Angle-closure glaucoma suspect
Exclusion Criteria
* Previous intraocular surgery
* Visual acuity worse than 20/40
* Prior episode of acute angle-closure glaucoma
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of the Incarnate Word
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Trevino, OD, FAAO
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Trevino, OD
Role: PRINCIPAL_INVESTIGATOR
University of the Incarnate Word
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of the Incarnate Word
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-02-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.